Business Context and Reporting Period
This Form 6-K filing by Ambev S.A. covers the period from November 1 to November 30, 2020. The report discloses transactions in securities and derivatives involving the company's Group and Related Persons, Board of Directors, Management, and Fiscal Council, in compliance with Article 11 of CVM Instruction #358/2002. The filing was signed on December 10, 2020.
Key Financial Metrics
The filing text does not provide revenue, profit, cash flow, margins, debt, or liquidity metrics. This document is strictly a disclosure of insider and related party securities transactions.
Transaction details reported include:
- Group and Related Persons: No transactions occurred during the month. Initial and final balances remained at 32,300,347 Common Shares and 1,068,738 ADRs.
- Management: Two option exercises occurred on November 30, 2020, directly with the company at a price of R$ 9.35960 per share.
- Fiscal Council: No transactions occurred; holdings remained at 0 Common Shares.
Material Changes
Material changes were limited to the Management category:
- Common Shares: Increased from an initial balance of 5,128,911 to a final balance of 5,283,136.
- Transaction Volume: A total of 154,225 shares were acquired via option exercises (97,000 shares and 57,225 shares).
- Transaction Value: The total volume for these transactions was R$ 1,443,484.31 (R$ 907,881.20 + R$ 535,603.11).
- ADRs: No change in ADR holdings for Management (268,126 shares).
Guidance, Outlook, and Risks
The filing text does not provide guidance, outlook, management commentary on operations, risks, contingencies, or unusual items. The document is a regulatory compliance form regarding specific securities transactions.
Investor Verification Checklist
- Verify the total number of shares exercised by Management (154,225) against the company's equity compensation plan limits.
- Confirm the exercise price of R$ 9.35960 aligns with the strike price of the specific options granted.
- Review the "Group and Related Persons" holdings to ensure no undisclosed transactions occurred outside the reported zero-activity month.
- Check subsequent filings for the impact of these option exercises on diluted earnings per share.